Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Full Year 2021 Takeda Pharmaceutical Co Ltd Earnings Press Conference Transcript

May 11, 2021 / 07:30AM GMT
Release Date Price: $16.71 (-1.47%)
Operator

Good day, everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. (Operator Instructions)

Now we start the conference. Ms. Ohyabu, please go ahead.

Takako Ohyabu
Takeda Pharmaceutical Company Limited - Chief Global Corporate Affairs Officer

[Interpreted] Thank you very much for joining us in this FY 2020 Earnings Conference Call. I serve as a moderator today, Chief Global Corporate Affairs Officer, Takako Ohyabu.

Before we start, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in the most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 2 of today's presentation.

Today from our side, we have presenters and the discussions in the Q&A session, President and CEO, Christophe Weber; and Chief Financial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot